Trial of Nivolumab With FOLFOX After Chemoradiation in Rectal Cancer Patients
Trial of Nivolumab With FOLFOX After Chemoradiation in Rectal Cancer Patients
Active, not recruiting · NCT03921684 · Registry updated 2026-01-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Trial of Nivolumab With FOLFOX After Chemoradiation in Rectal Cancer Patients | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal cancer, rectal disorder, rectal neoplasm | Active, not recruiting | Phase 2 | 2026-01-05 | NCT03921684 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Baruch Brenner | 2 |
| Bristol-Myers Squibb | 422 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Rabin Medical Center, Beilinson Hospital | Petah Tikva | Israel | 4 |